 Visit the TF Network Sites · Institutional Investor Center · Individual Investor Center |
| Download Plug-In |
| Real
Player 8 Basic Windows Media Player |
| Other Conference Calls |
| Other May 7 Calls Today's Calls |
| Call Details | |||
| Hospira Earnings Conference Call (Q1 2008) Wed, May 7, 2008, 9:00 am Eastern
| |||
| About Hospira (NYSE:HSP) | |||
| Hospira, Inc., a pharmaceutical and medication delivery company, engages in the development, manufacture, and marketing of specialty injectable pharmaceuticals and medication delivery systems that deliver drugs and intravenous (I.V.) fluids in the United States and internationally. It offers specialty injectable pharmaceuticals, which include injectable generic drugs in various dosages and formulations used in therapeutic areas, such as analgesia, anesthesia, anti-infective, cardiovascular, and oncology, as well as provides Precedex, a proprietary drug for sedation. The company also manufactures medication management systems that comprise electronic pumps and sets for I.V. drug delivery, and patient-controlled analgesia devices for pain management; Hospira MedNet safety software system; and I.V. solutions, nutritional products, and gravity sets. In addition, Hospira offers contract manufacturing services consisting of formulation development, filling, and finishing of injectable pharmaceuticals for pharmaceutical and biotechnology companies. Further, the company develops and manufactures hemodynamic monitoring systems used in the intensive care setting, critical care units to measure cardiac output and blood flow, and brain-function monitoring devices. It serves pharmaceutical and biotechnology companies, hospitals, clinics, home healthcare providers, and long-term care facilities. The company was founded in 2003 and is headquartered in Lake Forest, Illinois. Hospira Inc. (NYSE:HSP) operates independently of Abbott Laboratories as of April 30, 2004. | |||
More Info: | |||
